Tatjana Novakovic

Dr. Tatjana Novakovic


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Medical Archives
Verified
Journal Article
Open access
PDF file
TNTatjana Novakovic
Tatjana Novakovic
MMMevludin Mekic
Mevludin Mekic
LSLjiljana Smilic
Ljiljana Smilic
TSTanja Smilic
Tanja Smilic
BIBiljana Ini
Biljana Ini
SMSrbislava Milinic
Srbislava Milinic
Non-alcoholic (NAFLD) encompasses a spectrum of disease states, from steatosis (fatty liver) to non-alcoholic steatohepatitis (also called NASH steatosis with inflammatory changes) followed by progression to fibrosis and cirrhosis and hepatocellular carcinoma Excess liver fat is believed to be a manifestation of the metabolic syndrome and not surprisingly NASH is associated with obesity, insulin resistance, dyslipidemia and type 2 diabetes in humans. is to establish anthropometric and biochemical specificities in patients with non-alcoholic steatohepatitis diagnosed with non-invasive diagnostic methods Study enrolled 170 participants, 130 with NASH steatosis. The non-alcoholic group (control), consisted of 40 normal weight patients without metabolic syndrome. Alcohol intake was estimated with established protocol. Routine biochemistry analysis were performed by standard laboratory procedures; serum levels of serum levels of fasting cholesterol and triglycerides, fasting glucose and insulin, insulin resistance estimated by HOMA index (Homeostasis model assessment), biochemistry tests and a liver ultrasound examination. In study participants group, patients were more obese comparing with controls p < 0, 01, waist line extent also was of greater statistical significance in the non-alcoholic group fatty liver (p < 0, 01). Comparing biochemical parameter values, significant statistical deference has been noted in glaucosis and insulin levels, total cholesterol and gama-glutamil transferase levels, between groups (p<0, 01). Fasting glucose and insulin levels, HOMA-IR were significantly greater in study cohort group patients, as was significantly positive correlation between BMI and waist line extent. Patients with non-alcoholic fatty liver are excessively obese, have greater waist line extent, consequently insulin resistance and impaired glucose metabolism, insulin resistance, dyslipidemia, risk factors known to be associated with the development of cardiovascular disease.

1 January 2013 in Medicinski Pregled
Verified
Journal Article
Open access
PDF file
TNTatjana Novakovic
Tatjana Novakovic
BIBiljana Inic-Kostic
Biljana Inic-Kostic
SMSrbislava Milinic
Srbislava Milinic
LJLjiljana Jovicevic
Ljiljana Jovicevic
GDGordana Dzeletovic
Gordana Dzeletovic
Introduction. Clinical, epidemiological and biochemical studies strongly support the concept that the non-alcoholic fatty liver disease is a hepatic manifestation of the metabolic syndrome. Insulin resistance is a common factor connecting obesity, diabetes, hypertension and dyslipidemia with fatty liver and the progression of hepatic disease to steatohepatitis, fibrosis, cirrhosis and hepatocellular carcinoma. Since identification of cardiovascular risk factors is the first step in their prevention, the aim of this study was to analyze the prevalence of some risk factors in patients with fatty liver. Material and Methods. The study included 130 patients who met metabolic syndrome criteria; their demographic and anthropometric characteristics were analyzed and some clinical characteristics were determined, such as smoking habit, arterial pressure and alcohol intake. Routine biochemical analyses were carried out by a standard laboratory procedure. Hepatic steatosis was detected by the abdominal ultrasound. Modified criteria of the National Cholesterol Education Program Adult Treatment Panel III were used to describe the metabolic syndrome. Results. The study group consisted of 72 subjects (55.38%), who had been found by ultrasound to have fatty liver, whereas the control group included 58 respondents (44.62%) without pathological ultrasound findings. Differences in the number of fatty liver were highly statistically significant between the groups. The values of body mass index (33.56?6.05 vs 30.56?4.23 kg/m2; p = 0.001), glucose (6.23?0.95 vs 5.76?0.88 mmol/l; p

23 February 2013 in Medical Journal of Montenegro
Verified
Journal Article
Open access
LJLjiljana Jovićević
Ljiljana Jovićević
ILItana Labović
Itana Labović
NTNataša Terzić
Nataša Terzić
RSRajko Strahinja
Rajko Strahinja
TNTatjana Novakovic
Tatjana Novakovic
SBSnežana Barjaktarović-Labović
Snežana Barjaktarović-Labović
Nivo informisanosti o HIV/AIDS-u i drugim polno prenosivim infekcijama među turističkim radnicima u Crnoj Gori

15 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
KDKatarina Dunjic
Katarina Dunjic
MDMomir Dunjic
Momir Dunjic
MJMarina Gazdic Jankovic
Marina Gazdic Jankovic
MKMarina Miletic Kovacevic
Marina Miletic Kovacevic
Nikolina KastratovicNikolina Kastratovic
Nikolina Kastratovic
STStefano Turini
Stefano Turini
Background: Malignant melanoma is characterized by molecular heterogeneity, adap-tive signaling, and limited durability of therapeutic responses. This exploratory study examined a chemically characterized dual-oil formulation composed of cold-pressed Prunus dulcis oil and Pinus sylvestris needle essential oil as an integrated life-science model linking formulation chemistry, comparator-context molecular docking, and cel-lular viability. Methods: GC-MS/FAME profiling defined the principal formula-tion-associated markers. Docking was used to prioritize structurally plausible interac-tions across a melanoma-relevant target panel, while Neutral Red Uptake assays quan-tified 24-h viability in B16F10 melanoma cells and MRC-5 fibroblasts. Spearman rank analysis was applied to the concentration–viability series to test monotonic biological coherence; a direct component-level docking-to-cellular correlation was prospectively evaluated for estimability. Results: The combined formulation yielded estimated IC50 values of 1.42% in B16F10 cells and 4.85% in MRC-5 cells (selectivity index, 3.41). Across the complete concentration range, the relationship was non-monotonic (B16F10: ρs = −0.429, p = 0.289; MRC-5: ρs = −0.381, p = 0.352), whereas the descending high-dose branch (≥0.37% v/v) showed strong inverse rank associations (B16F10: ρs = −1.000, p < 0.001; MRC-5: ρs = −0.900, p = 0.037). A statistically valid direct in silico–in vitro Spear-man coefficient could not be calculated because compound-resolved cellular pheno-types were unavailable for the six docked chemical markers. Conclusions: The data support a biologically coherent, concentration-dependent cytotoxic phenotype within the descending exposure range and define a rigorous framework for future com-pound-matched computational–experimental validation. The study should be inter-preted as hypothesis-generating rather than as evidence of cellular target engagement or therapeutic efficacy.

22 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
KDKatarina Dunjic
Katarina Dunjic
MDMomir Dunjic
Momir Dunjic
MJMarina Gazdic Jankovic
Marina Gazdic Jankovic
MKMarina Miletic Kovacevic
Marina Miletic Kovacevic
Nikolina KastratovicNikolina Kastratovic
Nikolina Kastratovic
STStefano Turini
Stefano Turini
Background: Malignant melanoma remains a biologically aggressive cancer in which pathway redundancy and adaptive signaling can complicate durable therapeutic control. The working hypothesis is based on the following testable question: whether an archived dual-oil formulation composed of cold-pressed Prunus dulcis oil and Pinus sylvestris oil, in which α-pinene is the major component, generated a measurable NRU viability phenotype in B16F10 melanoma cells that justified subsequent standardized chemical, mechanistic, and statistical follow-up. Methods: Comparator-context docking observations were generated across a melanoma-relevant target panel, and the computational layer was used only to organize qualitative pocket-context hypotheses. The archived NRU dataset was then descriptively evaluated in B16F10 melanoma cells and MRC-5 fibroblasts. Results: The NRU data indicate an observable concentration-associated reduction in B16F10 viability for the combined formulation; and IC50/selectivity-index values were estimated from fitted dose-response curves; however, the absence of complete replicate-level raw metadata and confidence intervals requires cautious exploratory interpretation. Conclusions: The results support the cautious interpretation that a dual-oil P. dulcis and P. sylvestris formulation may serve as a pilot, hypothesis-generating anti-melanoma exploratory platform. The principal value of the study is to define the minimum experimental program required for future validation, including GC-MS batch standardization, orthogonal viability assays, replicated dose-response modeling, biochemical target assays, pathway readouts, and in vivo evaluation where justified. GC-MS/FAME profiling is incorporated as a chemical-standardization anchor for the dual-oil system. GC/MS analysis was performed to characterize the chemical profiles of cold-pressed P. dulcis oil and P. sylvestris needle essential oil, supporting chemical standardization of the dual-oil system.

Verified
Journal Article
Open access
PDF file
MDMomir Dunjic
Momir Dunjic
STStefano Turini
Stefano Turini
TNTatjana Novakovic
Tatjana Novakovic
LNLazar Nejkovic
Lazar Nejkovic
JZJing Zhao
Jing Zhao
KDKatarina Dunjic
Katarina Dunjic
Localized phytochemical formulations may provide complementary strategies for controlling mucosal colonization by Streptococcus agalactiae and Streptococcus pyogenes, but computational prioritization requires orthogonal biological validation. This study integrated molecular docking against the redox-sensing transcriptional repressor Rex of S. agalactiae and a protein tyrosine phosphatase target of S. pyogenes (SP-PTP) with in vitro broth microdilution, biofilm, target-bridging, and epithelial-tolerance experiments. Isoflavone showed the most favorable natural-compound interaction with Rex (ΔG = −8.3 kcal/mol), whereas secoisolariciresinol diglucoside (SDG) led the natural-ligand ranking for SP-PTP (ΔG = −5.2 kcal/mol). The complete formulation produced MIC50 values of 0.031% and 0.063% v/v against S. agalactiae and S. pyogenes, respectively; inhibited biofilm formation by 89.2% and 80.1%; and preserved >92% epithelial viability at 1× MIC. Among the three natural candidates with complete matched broth data, target-normalized docking and composite MIC50/MIC90/MBC50 ranks were perfectly concordant in both species; pooled species-stratified Spearman analysis yielded ρ = 1.000 (exact p = 0.0556; n = 6). In contrast, the extended panel including antibacterial comparators showed negligible concordance (ρ = 0.081; p = 0.7826; n = 14). Principal component analysis assigned 74.8% of variance to an in vitro potency axis and 24.6% to a largely orthogonal docking axis. Thus, the experiments confirmed the target-specific ordering of the natural candidates but did not support extrapolation of docking rank across mechanistically heterogeneous antibacterial classes. Intracellular target inhibition, genetic causality, and component synergy remain unestablished.